Navigating adalimumab biosimilars: an expert opinion

• मुख्य लेखकों: Vered Abitbol (लेखक), Salim Benkhalifa (लेखक), Caroline Habauzit (लेखक), Hubert Marotte (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Becaris Publishing Limited, 2023-10-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

The patent expiry of Humira in 2018 opened up the current European market to eight adalimumab biosimilars - (in alphabetical order) Amgevita, Amsparity, Hulio, Hukyndra, Hyrimoz, Idacio, Imraldi and Yuflyma - for the treatment of various immune and inflammatory conditions. Amjevita, Hadlima, Hyrimoz...